The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study.
Sato S, Ssuzuki T, Chinen T, Yamaguchi H, Suzuki Y, Hokamura N, Saze Z, Kono K, Takahashi K, Yano F, Kunisaki C, Kosaka T, Endo I, Ichikawa Y, Miyawaki Y, Sato H, Shimada H.
Sato S, et al. Among authors: yano f.
Int J Clin Oncol. 2024 Apr 28. doi: 10.1007/s10147-024-02532-0. Online ahead of print.
Int J Clin Oncol. 2024.
PMID: 38679627